杭州地区血脂调节药的利用分析

Utilization Analysis of Liporegulators in Hangzhou Area

目的了解杭州地区血脂调节药的临床应用情况及趋势。方法利用《医院处方分析》课题数据,对杭州地区7家三甲医院和4家二甲医院2006年及2007年门诊、病房血脂调节药的应用情况进行比较。结果血脂调节药的销售金额及患者使用人次有逐年上升趋势,销售金额和总治疗人次日(TPD)最高的均为阿托伐他汀(立普妥)。结论他汀类药物占据杭州地区血脂调节药市场的主导地位,在品种选择上体现了有效性、安全性和多样性等特点。

Objective To evaluate the status quo and trend of the clinical utilization of liporegulators in Hangzhou area. Methods By applying the project Analysis of Prescriptions in Hospital, the prescription data of liporegulators in 7 grade 3a hospitals and 4 grade 2a hospitals in Hangzhou area during the period of 2006- 2007 were analyzed and compared. Results Both the numbers of the patients us- ing and the consumption sum of the liporegulators in Hangzhou area increased year by year. Atorvastatin dominated over all other drugs in respect of consumption sum and TPD. Conclusion Statins has occupied the main position in the market of liporegulators in Hangzhou area. The choice of drug variety is characterized by efficacy, safety and diversity, etc.